blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1012300

EP1012300 - HNK-1 SULFOTRANSFERASE AND METHODS OF USE THEREFOR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.01.2004
Database last updated on 25.09.2024
Most recent event   Tooltip09.01.2004Application deemed to be withdrawnpublished on 25.02.2004  [2004/09]
Applicant(s)For all designated states
Acorda Therapeutics
15 Skyline Drive
Hawthorne, NY 10531 / US
[2000/26]
Inventor(s)01 / MANTEI, Ned
Riedhofstrasse 372
CH-8049 Zurich / CH
02 / BAKKER, Hendrikus
Meerburgerkade 78
NL-2314 VS Leiden / NL
03 / SCHACHNER, Melitta
Ekkehardstrasse 8
CH-8006 Zurich / CH
[2000/26]
Representative(s)Mercer, Christopher Paul, et al
Carpmaels & Ransford LLP
One Southampton Row
London
WC1B 5HA / GB
[N/P]
Former [2000/26]Mercer, Christopher Paul, et al
Carpmaels & Ransford 43, Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date98946870.704.09.1998
[2000/26]
WO1998US18572
Priority number, dateUS1997092481205.09.1997         Original published format: US 924812
[2000/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9911796
Date:11.03.1999
Language:EN
[1999/10]
Type: A1 Application with search report 
No.:EP1012300
Date:28.06.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 11.03.1999 takes the place of the publication of the European patent application.
[2000/26]
Search report(s)International search report - published on:EP11.03.1999
ClassificationIPC:C12N15/54, C12N9/10, C12N15/86, C12N5/10, A61K31/70, C07K19/00, C07K16/40, A61K48/00
[2000/26]
CPC:
C12N9/13 (EP); A61K38/00 (EP); A61K48/00 (EP);
C07K2319/00 (EP)
Designated contracting statesCH,   DE,   FR,   GB,   LI [2000/26]
TitleGerman:HNK-1 SULFOTRANSFERASE UND VERFAHREN ZU IHRER VERWENDUNG[2000/26]
English:HNK-1 SULFOTRANSFERASE AND METHODS OF USE THEREFOR[2000/26]
French:SULFOTRANSFERASE HNK-1 ET SES METHODES D'UTILISATION[2000/26]
Entry into regional phase06.04.2000National basic fee paid 
06.04.2000Designation fee(s) paid 
05.04.2000Examination fee paid 
Examination procedure01.04.1999Request for preliminary examination filed
International Preliminary Examining Authority: US
05.04.2000Examination requested  [2000/33]
29.01.2003Despatch of a communication from the examining division (Time limit: M06)
09.08.2003Application deemed to be withdrawn, date of legal effect  [2004/09]
12.09.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2004/09]
Fees paidRenewal fee
06.04.2000Renewal fee patent year 03
12.09.2001Renewal fee patent year 04
12.09.2002Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.09.200306   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]  - KOJI TERAYAMA ET AL., "Cloning and functional expression of a novel glucuronyltransferase involved in the biosynthesis of the carbohydrate epitope HNK-1", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, WASHINGTON US, (19970610), vol. 94, no. 12, pages 6093 - 6098, XP002087867 [DA] 1-28 * abstract * * page 6097, column L, paragraph 2 - column R, paragraph 2 *

DOI:   http://dx.doi.org/10.1073/pnas.94.12.6093
 [DA]  - AMJAD A. ILYAS ET AL., "Variability in the structural requirements for binding of human monoclonal anti-myelin-associated glycoprotein immunoglobulin <<
 [DA]  - KOICHI HONKE ET AL., "Purification and characterization of 3'-Phosphoadenosine-5'-Phosphosulfate:GalCer Sulfotransferase from human renal cancer cells", THE JOURNAL OF BIOCHEMISTRY, (199603), vol. 119, no. 3, pages 421 - 426, XP002087869 [DA] 1-28 * the whole document *
 [PX]  - BAKKER H ET AL, "Expression cloning of a cDNA encoding a sulfotransferase involved in the biosynthesis of the HNK -1 carbohydrate epitope.", JOURNAL OF BIOLOGICAL CHEMISTRY, (1997 NOV 21) 272 (47) 29942-6. JOURNAL CODE: HIV. ISSN: 0021-9258., United States, XP002087870 [PX] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.272.47.29942
 [PX]  - ONG E ET AL, "Expression cloning of a human sulfotransferase that directs the synthesis of the HNK -1 glycan on the neural cell adhesion molecule and glycolipids.", JOURNAL OF BIOLOGICAL CHEMISTRY, (1998 FEB 27) 273 (9) 5190-5. JOURNAL CODE: HIV. ISSN: 0021-9258., United States, XP002087871 [PX] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.273.9.5190
 [PX]  - R55u061 Database Entry Af070594 Accession number AF070594; 5 August 1998 YU W. ET AL.:"Homo sapiens clone 24570 HNK-1 sulfotransferase mRNA, complete cds.", XP002087872 [PX] 8-15,20,23-25 * the whole document *
 [PX]  - Emhum1 Database Entry Af033827 Accession number AF033827; 10 March 1998 ONG E. ET AL.:"Homo sapiens HNK-1 sulfotransferase mRNA, complete cds.", XP002087873 [PX] 8-15,20,23-25 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.